1 unknown. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Unknown 1 |
Follow Li Yu: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Study of DC-CIK Cells as a Post-remission Treatment for Malignant Tumors Decitabine, DC-CIK - Malignant Neoplasm | Phase 3 | Unknown | Li Yu | 200 | 2020-01-21 | 2020-03-03 |
Neoplasms (1)
Decitabine (1)
China (1)